Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 27, 2023

SELL
$229.71 - $259.35 $12,404 - $14,004
-54 Reduced 5.77%
882 $218,000
Q4 2022

Jan 27, 2023

SELL
$218.29 - $256.91 $1,091 - $1,284
-5 Reduced 0.53%
936 $0
Q3 2022

Nov 01, 2022

SELL
$51.03 - $264.23 $204 - $1,056
-4 Reduced 0.42%
941 $210,000
Q2 2022

Jul 28, 2022

SELL
$234.74 - $275.42 $444,128 - $521,094
-1,892 Reduced 66.69%
945 $233,000
Q1 2022

Apr 29, 2022

BUY
$243.64 - $270.48 $327,452 - $363,525
1,344 Added 90.02%
2,837 $755,000
Q4 2021

Jan 18, 2022

BUY
$230.08 - $250.94 $920 - $1,003
4 Added 0.27%
1,493 $375,000
Q3 2021

Oct 14, 2021

BUY
$232.72 - $256.47 $346,520 - $381,883
1,489 New
1,489 $366,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.2B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Latitude Advisors, LLC Portfolio

Follow Latitude Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Latitude Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Latitude Advisors, LLC with notifications on news.